Your spot on BD. The number if patients they are having to screen would blow you away. It really is that difficult to find qualified patients. I know Pears feels regardless it should have been enrolled long ago. It really is that complex and also add into the mix the limited resources that BP would have to ramp up the screening process. This was/is a very difficult trial to enroll. Good news is IMO company already know Combo PE is done. Just need the FDA to put its stamp on it.
News 
Market Data 
Discover 
